7% versus 15.4%) (P = .009). Overall survival in the non-ATG group was slightly higher than that of the ATG cohort (64.1% versus 52.1%, P = .093) and leukemia-free survival in the non-ATG cohort was significantly Anlotinib datasheet higher than in the ATG cohort (56.6% versus 37.7%, P = .015). Our study demonstrated that, for high-risk or advanced childhood hematological malignancies receiving unrelated CBT, patients who received conditioning that omitted ATG had a faster platelet recovery, a comparable GVHD and TRM, a significantly lower relapse risk, and

an improved long-term survival compared with those patients who received ATG in the conditioning. (C) 2015 American Society for Blood and Marrow Transplantation.”
“PURPOSE. We determined the selleck inhibitor relationship between total optic nerve axon counts and peripapillary retinal nerve fiber layer thickness (RNFLT) measured in vivo by spectral

domain optical coherence tomography (SDOCT).\n\nMETHODS. A total of 22 rhesus macaques had three or more baseline measurements in both eyes of peripapillary RNFLT made by SDOCT. Laser photocoagulation then was applied to the trabecular meshwork of one eye to induce chronic unilateral IOP elevation. SDOCT measurements of RNFLT continued approximately every two weeks until the predefined study endpoint was reached in each animal. At endpoint, animals were sacrificed and the optic nerve was sampled approximately 2 mm behind the globe to obtain thin sections for histologic processing and automated axon counting across 100% of the optic nerve cross-sectional area.\n\nRESULTS. At the final imaging session, the average loss of RNFLT was 20 +/- 21%, ranging from essentially no loss to nearly 65% loss. Total optic nerve axon count in control eyes ranged from 812,478 GDC973 to 1,280,474. The absolute number of optic

nerve axons was related linearly to RNFLT (axon count 12,336 3 RNFLT(mu m) – 257,050, R-2 = 0.65, P < 0.0001), with a Pearson correlation coefficient of 0.81. There also was a strong linear relationship between relative optic nerve axon loss (glaucomatous-to-control eye) and relative RNFLT at the final imaging session, with a slope close to unity but a significantly negative intercept (relative axon loss((%)) 1.05Xrelative RNFLT loss((%)) – 14.4%, R-2 = 0.75, P < 0.0001). The negative intercept was robust to variations of fitted model because relative axon loss was -14% on average for all experimental glaucoma (EG) eyes within 6% (measurement noise) of zero relative loss.\n\nCONCLUSIONS. There is a strong linear relationship between total optic nerve axon count and RNFLT measured in vivo by SDOCT. However, substantial loss of optic nerve axons (similar to 10%-15%) exists before any loss of RNFLT manifests and this discrepancy persists systematically throughout a wide range of damage. (Invest Ophthalmol Vis Sci. 2012;53:7766-7773) DOI:10.1167/iovs.